Clinical trials
Phase 1/2 Lymphoma, T-Cell, Peripheral trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 3 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
| Unknown status | 5 |
| Active, not recruiting | 2 |
| Completed | 2 |
| Not yet recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 5 |
| Peking Union Medical College Hospital | 3 |
| Ruijin Hospital | 3 |
| Haihe Biopharma Co., Ltd. | 2 |
| Akeso | 1 |
| Antengene Corporation | 1 |
| AstraZeneca | 1 |
| Beijing Biotech | 1 |
| Dizal Pharmaceuticals | 1 |
| Evopoint Biosciences Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Peripheral | 25 |
| Recurrence | 7 |
| Lymphoma, Non-Hodgkin | 3 |
| Lymphoma, Follicular | 2 |
| Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 |
| Burkitt Lymphoma | 1 |
| Hematologic Neoplasms | 1 |
| Hodgkin Disease | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Leukemia, Plasma Cell | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.